Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05452941 · ClinicalTrials.gov registry record
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
A clinical trial of Pneumonia, sponsored by Pfizer.
- Recruiting
- Registry status
- 12,500
- Enrollment target
- 20
- Study locations
NCT05452941 is a study of Pneumonia that is actively recruiting participants, run by Pfizer. The registered enrollment target is 12,500 participants, above the 4,254-participant average among 47 other Pneumonia trials with a reported enrollment target (194% higher). The trial reports 20 study locations across 1 state.
The verdict
NCT05452941, a study of Pneumonia, is actively recruiting participants, sponsored by Pfizer.
- RECRUITING
- Registry status
- 12,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to learn about how well the 20-valent pneumococcal conjugate vaccine (20vPnC) works against radiologically-confirmed community-acquired pneumonia (RAD+CAP) due to the 7 new serotypes (types of a bacteria called Streptococcus pneumoniae that cause pneumonia) included in 20vPnC vaccine. This study is seeking participants who: * are male or female ≥65 years of age. * are hospitalized with physician suspicion of community acquired pneumonia (CAP). * have pneumonia confirmed with imaging like a chest x-ray Participants will be asked to provide demographic and medical history information, and to provide a urine sample that will be used to test for pneumonia caused by specific strains of a bacteria called Streptococcus pneumoniae. We will compare the proportion of participants who have pneumonia caused by specific strains of the bacteria Streptococcus pneumoniae and were previously vaccinated with 20vPnC with the proportion of participants who have pneumonia caused by something other than vaccine type Streptococcus pneumoniae and have been vaccinated with 20vPnC. Participants will actively take part in the study for about 1-2 days. Information on participant's illness and hospitalization details will be collected through day 30 of their hospitalization through medical chart review.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Diagnostic test on urine samples
Study Locations (20)
California
- Kaiser Permanete Baldwin Park - Baldwin Park
- Kaiser Permanete Downey - Downey
- El Centro Regional Medical Center - El Centro
- Kaiser Permanente Fontana Medical Center - Fontana
- University of California San Francisco - Fresno - Fresno
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- Kaiser Permanente - Los Angeles
- Kaiser Permanente West Los Angeles Medical Center - Los Angeles
- Kaiser Permanente Vaccine Study Center - Oakland
- Kaiser Permanente Oakland Medical Center - Oakland
- Kaiser Permanente Ontario Medical - Ontario
- Southern California Permanente Medical Group (SCPMG) - Pasadena
- Kaiser Permanente Riverside Medical Center - Riverside
- Kaiser Permanente Roseville Medical Center - Roseville
- Kaiser Permanente South Sacramento Medical Center - Sacramento
- Kaiser Permanente Sacramento Medical Center - Sacramento
- Kaiser Permanente Zion Medical Center - San Diego
- Kaiser Permanente San Diego Medical Center - San Diego
- Kaiser Permanente San Jose Medical Center - San Jose
- Kaiser Permanente Santa Clara Medical Center - Santa Clara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,500 participants |
| Start Date | 2022-10-27 |
| Est. Completion | 2027-06-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05452941
The ClinicalTrials.gov registry entry for NCT05452941 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 12,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,254-participant average among 47 other Pneumonia trials with a reported enrollment target (194% higher). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which Diagnostic test on urine samples is the first listed.
NCT05452941 reports 20 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05452941 about?
NCT05452941 is a clinical study titled "A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting". The purpose of this study is to learn about how well the 20-valent pneumococcal conjugate vaccine (20vPnC) works against radiologically-confirmed community-acquired pneumonia (RAD+CAP) due to the 7 new serotypes (types of a bacteria called Streptococcus pneumoniae that cause pneumonia) included in 2...
What is the current status of trial NCT05452941?
This trial is currently recruiting. The enrollment target is 12,500 participants. The study started on 2022-10-27. Estimated completion is 2027-06-04.
What conditions does trial NCT05452941 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT05452941?
The interventions under investigation include: Diagnostic test on urine samples (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05452941?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05452941 being conducted?
This trial has 20 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.